BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29990555)

  • 21. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
    Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X
    Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
    Jiang H; Zhao PJ; Su D; Feng J; Ma SL
    Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
    Li R; Liu GZ; Luo SY; Chen R; Zhang JX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
    Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
    Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
    Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
    PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
    Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma-bearing mice.
    Zhu J; Xu J; Jiang LL; Huang JQ; Yan JY; Chen YW; Yang Q
    Kaohsiung J Med Sci; 2019 Apr; 35(4):222-229. PubMed ID: 30958641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Human Serum Albumin-Cisplatin Complex in U87MG Xenograft Mouse Models.
    Park CR; Kim HY; Song MG; Lee YS; Youn H; Chung JK; Cheon GJ; Kang KW
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
    Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
    Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor activity of polysaccharides isolated from Patrinia scabra Bunge on U14 cervical carcinoma bearing mice.
    Lu WZ; Geng GX; Li QW; Li J; Liu FZ; Han ZS; Gao DW; Yan X; Yang XL
    Am J Chin Med; 2009; 37(5):933-44. PubMed ID: 19885953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.
    Uzawa K; Kasamatsu A; Baba T; Usukura K; Saito Y; Sakuma K; Iyoda M; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H
    Cancer Med; 2013 Feb; 2(1):40-9. PubMed ID: 24133626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
    Padilla LA; Leung BS; Carson LF
    Gynecol Oncol; 2002 Apr; 85(1):59-66. PubMed ID: 11925121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSH triggered intracellular aggregated-cisplatin-loaded iron oxide nanoparticles for overcoming cisplatin resistance in nasopharyngeal carcinoma.
    Bejjanki NK; Xu H; Xie M
    J Biomater Appl; 2021 Jul; 36(1):45-54. PubMed ID: 33402041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergic Effect of
    Pérez-Rojas JM; González-Macías R; González-Cortes J; Jurado R; Pedraza-Chaverri J; García-López P
    Oxid Med Cell Longev; 2016; 2016():7981397. PubMed ID: 28053694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor effect of polysaccharide from Hirsutella sinensis on human non-small cell lung cancer and nude mice through intrinsic mitochondrial pathway.
    Liu WB; Xie F; Sun HQ; Meng M; Zhu ZY
    Int J Biol Macromol; 2017 Jun; 99():258-264. PubMed ID: 28235606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
    Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.